Austco Healthcare Ltd

Austco Healthcare maintains a strong liquidity position, with a current ratio of 1.56 and cash and equivalents of AUD 14.48 million, indicating the company can meet its short-term obligations comfortably. The company's price-to-book ratio of 2.35 and a debt-to-equity ratio of 0.14 suggest a conservative capital structure with limited leverage. Profitability metrics show a return on equity of 11.47% and a return on assets of 6.52%, which are in line with industry norms for medical equipment and supplies. The company's operating margin of 9.9% (calculated from operating income of AUD 8.06 million on revenue of AUD 81.41 million) reflects efficient cost management and pricing power. Geographically, Austco Healthcare's revenue is concentrated in its domestic market, with no disclosed international revenue segments. The company operates in a single business segment focused on healthcare communication solutions, with no material diversification across product lines or geographic regions. The company's revenue growth is expected to remain stable, with no significant changes in the current fiscal year. Historical revenue of AUD 81.41 million and a free cash flow of AUD 4.06 million indicate a solid cash-generating business model. However, the absence of disclosed capital expenditure plans beyond the current year suggests limited near-term growth investments. Risk factors include low liquidity and dilution risk, with no immediate filing-based flags detected. The company's low debt levels and strong cash position reduce credit risk, but its reliance on a single product line and domestic market exposure could limit resilience in a downturn. Recent events include the continued development of its Pulse Mobile and Pulse Reports platforms, which enhance clinical workflow and data analytics. No recent filings or transcripts indicate material changes in strategy or operations.